Cargando…
Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing
Recent advances in lung cancer treatment are emerging from new immunotherapies that target T-cell inhibitory receptors, such as programmed cell death-1 (PD-1). However, responses to anti-PD-1 antibodies as single agents are observed in fewer than 20% of non-small-cell lung cancer (NSCLC) patients, a...
Autores principales: | Leclerc, Marine, Mezquita, Laura, Guillebot De Nerville, Guillaume, Tihy, Isabelle, Malenica, Ines, Chouaib, Salem, Mami-Chouaib, Fathia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616108/ https://www.ncbi.nlm.nih.gov/pubmed/31333652 http://dx.doi.org/10.3389/fimmu.2019.01505 |
Ejemplares similares
-
Resident memory T cells, critical components in tumor immunology
por: Mami-Chouaib, Fathia, et al.
Publicado: (2018) -
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
por: Durgeau, Aurélie, et al.
Publicado: (2018) -
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy
por: Damei, Isabelle, et al.
Publicado: (2023) -
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
por: Leclerc, Marine, et al.
Publicado: (2019) -
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
por: Ashi, Mohamad Omar, et al.
Publicado: (2022)